Newsmeme!
Discover News you didn't know existed
RICEVILLE — Jane Mosher and Larry Abel have a lot in common.
Story created Jul 07, 2009 - 10:49:51 CDT. Jane Mosher and Larry Abel have a lot in common. Neighbors separated by one house on Woodland Avenue since Larry and his family moved to Riceville in July 1987, both have fought and won the battle over cancer.
Peplin, Inc. (ASX:PLI) announced the completion of enrolment of its two Phase 3 clinical trials for the use of PEP005 (ingenol mebutate) Gel to treat actinic (solar) keratoses (AK), a common pre-cancerous skin lesion, on head treatment areas, which include the face and scalp. These Phase 3 clinical trials are referred to as REGION-IIa and REGION-IIb and enrolled approximately 250 patients each.
The National Institute for Health and Clinical Excellence (NICE) has announced that it will convene a guidance development group to formally review the recommendations relating to the diagnosis and removal of 'low risk' basal cell carcinomas (BCCs) in primary care in its guidance Improving Outcomes in Cancer for people with skin tumours including melanoma (2003).
Name one good thing about cancer. It can't be done. It has hit everyone. Dan (DJ) Shimek, a former Lourdes baseball pitcher/outfielder, included. Like most of us these days, he should be outside enjoying the summer months.
Eli Lilly and Company (NYSE: LLY) announced it received a fourth approval from the U.S. Food and Drug Administration (FDA) for ALIMTA® (pemetrexed for injection).
Eli Lilly and Company received a fourth approval from the US Food and Drug Administration (FDA) for Alimta (pemetrexed for injection).
EMERYVILLE, Calif. & BRISBANE, Australia----Peplin, Inc. today announced the completion of enrolment of its two Phase 3 clinical trials for the use of PEP005 Gel to treat actinic keratoses , a common pre-cancerous skin lesion, on head treatment areas, which include the face and scalp.
Scientists at deCODE genetics (Nasdaq: DCGN) and academic colleagues from Europe and the United States today present in the journal Nature Genetics the discovery of common genetic risk factors for basal cell carcinoma (BCC) that affect people with fair and dark complexions alike.
INDIANAPOLIS, July 6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) announced today it received a fourth approval from the U.S. Food and Drug Administration (FDA) for ALIMTA(R) (pemetrexed for injection).
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |